52-Week High Companies: HD, MMC, MMM, MYL, PFE

Author's Avatar
Sep 03, 2012
According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs: The Home Depot, Inc. (HD, Financial), Marsh & McLennan Companies, Inc. (MMC, Financial), 3M Co (MMM, Financial), Mylan Inc. (MYL, Financial), and Pfizer Inc. (PFE, Financial).

The Home Depot Inc. (HD) Reached the 52-Week High of $56.76



The prices of The Home Depot Inc. shares have reached $56.76, which is 0.4% off the 52-week high of $56.96. Home Depot is the one of world's largest home improvement retailer. The Home Depot, Inc. has a market cap of $86.87 billion; its shares were traded at around $56.76 with a P/E ratio of 20.56 and P/S ratio of 1.23. The dividend yield of The Home Depot, Inc. stocks is 2.04%. The Home Depot, Inc. had an annual average earnings growth of 5.3% over the past 10 years.

On Aug. 14, The Home Depot reported second quarter of fiscal 2012 net earnings of $1.5 billion, or $1.01 per diluted share, compared with net earnings of $1.4 billion, or $0.86 per diluted share, in the same period of fiscal 2011. For the second quarter of fiscal 2012, diluted earnings per share increased 17.4 percent from the same period in the prior year.

In August, Chairman & CEO Francis S Blake, CFO & EVP - Corp. Services Carol B Tome, EVP - Human Resources Timothy M Crow, and EVP - U.S. Stores Marvin R Ellison sold shares of HD stock. EVP & CIO Matt Carey and EVP - Merchandising Craig A Menear sold shares in March.

Marsh & McLennan Companies, Inc. (MMC) Reached the 52-Week High of $34.17



The prices of Marsh & McLennan Companies, Inc. shares have reached $34.17, which is 0.5% off the 52-week high of $34.35. Marsh & McLennan is primarily a holding company which, through its subsidiaries and affiliates, provides clients with analysis, advice and transactional capabilities in the fields of risk and insurance services, investment management and consulting. Marsh & McLennan Companies, Inc. has a market cap of $18.64 billion; its shares were traded at around $34.17 with a P/E ratio of 17.8 and P/S ratio of 1.62. The dividend yield of Marsh & McLennan Companies, Inc. stocks is 2.69%.

On Aug. 7, Marsh & McLennan Companies, Inc. reported financial results for the second quarter, ended June 30, 2012. Consolidated revenue in the second quarter of 2012 was $3 billion, an increase of 3%, or 5% on an underlying basis from the second quarter of 2011. Operating income rose 11% to $518 million. Adjusted operating income, which excludes noteworthy items as presented in the attached supplemental schedules, rose 13% to $523 million in the second quarter. Income from continuing operations in the second quarter of 2012 was $339 million, or $.60 per share, compared with $286 million, or $.50 per share, in the second quarter of 2011. Net income was $329 million, compared with $282 million in the second quarter of 2011.

Last month, President & CEO, Marsh Peter Zaffino sold 56,000 shares of MMC stock. President & CEO, Guy Carpenter Alexander S Moczarski sold 35,000 shares in June. Vice Chairman, Office of CEO David A Nadler, EVP & CFO Vanessa Ames Wittman, and SVP and Controller Robert J Rapport sold shares in March.

3M Co (MMM) Reached the 52-Week High of $92.61

The prices of 3M Company shares have reached $92.61, which is 1.8% off the 52-week high of $94.24. 3M Company is a diversified technology company with positions in consumer and office; display and graphics; electronics and telecommunications; health care; industrial; safety, security and protection services; transportation and other businesses. 3M Company has a market cap of $64.25 billion; its shares were traded at around $92.61 with a P/E ratio of 15.13 and P/S ratio of 2.17. The dividend yield of 3m Co stocks is 2.55%. 3M Company had an annual average earnings growth of 8.4% over the past 10 years. GuruFocus rated 3M Company the business predictability rank of 3.5-star.

On Apr 24, 3M reported record first-quarter sales of $7.5 billion, up 2.4 percent year-on-year. Earnings were $1.59 per share, an increase of 6.7 percent versus the first quarter of 2011, and operating margins for the quarter were 21.8 percent. First-quarter net income rose 4.0 percent year-on-year to over $1.1 billion and earnings were $1.59 per share, an increase of 6.7 percent versus last year's first quarter. Total-company operating income margins were 21.8 percent for the quarter, with five business segments above 20 percent, and free cash flow was $567 million.

Last month, EXEC VP R&D & CHF TECH OFF Fred J Palensky and EXEC VP HEALTH CARE Brad T Sauer sold shares of MMM stock. VICE PRESIDENT CORP SC OPERTNS John K Woodworth sold 30,532 shares in May.

Mylan Inc. (MYL) Reached the 52-Week High of $23.56



The prices of Mylan Inc. shares have reached $23.56, which is 1.4% off the 52-week high of $23.88. Mylan Inc. is one of the world's quality generic and specialty pharmaceutical companies. Mylan Inc. has a market cap of $10.1 billion; its shares were traded at around $23.56 with a P/E ratio of 10.71 and P/S ratio of 1.65. Mylan Inc. had an annual average earnings growth of 29.3% over the past 10 years. GuruFocus rated Mylan Inc. the business predictability rank of 2-star.

On July 26, Mylan Inc. announced its financial results for the three months ended June 30, 2012. Adjusted diluted EPS of $0.60 for the three months ended June 30, 2012 compared to $0.52 for the same prior year period, an increase of 15%. Total revenues of $1.69 billion for the three months ended June 30, 2012 compared to $1.57 billion for the same prior year period, an increase of 7%. On a GAAP basis, diluted EPS of $0.33 for both of the three month periods ended June 30, 2012 and 2011.

Last month, President, North America Anthony Mauro and President Rajiv Malik sold shares of MYL stock. Director Randall L Vanderveen and Executive Chairman Robert J Coury sold shares in May. Executive Chairman Robert J Coury sold 150,000 shares in April and CEO Heather M Bresch sold 197,306 shares in March.

Pfizer Inc. (PFE) Reached the 52-Week High of $23.86



The prices of Pfizer Inc. shares have reached $23.86, which is 1.8% off the 52-week high of $24.28. Pfizer Inc. is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer Inc. has a market cap of $178.67 billion; its shares were traded at around $23.86 with a P/E ratio of 10.28 and P/S ratio of 2.65. The dividend yield of Pfizer Inc. stocks is 3.69%. Pfizer Inc. had an annual average earnings growth of 0.5% over the past 10 years.

On July 31, Pfizer Inc. reported financial results for second-quarter 2012. Second-quarter 2012 revenues were $15.1 billion, a decrease of 9% compared with $16.5 billion in the year-ago quarter, which reflects an operational decline of $977 million, or 6%, and the unfavorable impact of foreign exchange of $451 million, or 3%. For second-quarter 2012, U.S. revenues were $5.7 billion, a decrease of 15% compared with the year-ago quarter. This decrease was primarily the result of the U.S. loss of exclusivity of Lipitor on November 30, 2011. International revenues were $9.3 billion, a decrease of 5% compared with the prior-year quarter, primarily due to the unfavorable impact of foreign exchange. U.S. revenues represented 38% of total revenues in second-quarter 2012 compared with 41% in the year-ago quarter, while international revenues represented 62% of total revenues in second-quarter 2012 compared with 59% in the year-ago quarter.

In May, Executive Vice President Douglas M Lankler sold 19,670 shares of PFE stock. Executive Vice President Charles H Hill sold 10,400 shares in March.